Yang Z - Search Results

1

Androgen receptor (AR) NH2- and COOH-terminal interactions result in the differential influences on the AR-mediated transactivation and cell growth.

Hsu CL, Chen YL, Ting HJ, Lin WJ, Yang Z, Zhang Y, Wang L, Wu CT, Chang HC, Yeh S, Pimplikar SW, Chang C. Hsu CL, et al. Among authors: yang z. Mol Endocrinol. 2005 Feb;19(2):350-61. doi: 10.1210/me.2004-0190. Epub 2004 Oct 28. Mol Endocrinol. 2005. PMID: 15514032

2

Androgen receptor regulates expression of skeletal muscle-specific proteins and muscle cell types.

Altuwaijri S, Lee DK, Chuang KH, Ting HJ, Yang Z, Xu Q, Tsai MY, Yeh S, Hanchett LA, Chang HC, Chang C. Altuwaijri S, et al. Among authors: yang z. Endocrine. 2004 Oct;25(1):27-32. doi: 10.1385/endo:25:1:27. Endocrine. 2004. PMID: 15545703

3

Induction of apolipoprotein E expression by TR4 orphan nuclear receptor via 5' proximal promoter region.

Kim E, Yang Z, Liu NC, Chang C. Kim E, et al. Among authors: yang z. Biochem Biophys Res Commun. 2005 Mar 4;328(1):85-90. doi: 10.1016/j.bbrc.2004.12.146. Biochem Biophys Res Commun. 2005. PMID: 15670754

4

Identification of steroid derivatives that function as potent antiandrogens.

Miyamoto H, Marwah P, Marwah A, Yang Z, Chung CY, Altuwaijri S, Chang C, Lardy H. Miyamoto H, et al. Among authors: yang z. Int J Cancer. 2005 Dec 10;117(5):866-72. doi: 10.1002/ijc.21217. Int J Cancer. 2005. PMID: 15981214

5

Transgelin functions as a suppressor via inhibition of ARA54-enhanced androgen receptor transactivation and prostate cancer cell growth.

Yang Z, Chang YJ, Miyamoto H, Ni J, Niu Y, Chen Z, Chen YL, Yao JL, di Sant'Agnese PA, Chang C. Yang Z, et al. Mol Endocrinol. 2007 Feb;21(2):343-58. doi: 10.1210/me.2006-0104. Epub 2006 Nov 2. Mol Endocrinol. 2007. PMID: 17082327

6

Suppression of androgen receptor transactivation and prostate cancer cell growth by heterogeneous nuclear ribonucleoprotein A1 via interaction with androgen receptor coregulator ARA54.

Yang Z, Chang YJ, Miyamoto H, Yeh S, Yao JL, di Sant'Agnese PA, Tsai MY, Chang C. Yang Z, et al. Endocrinology. 2007 Mar;148(3):1340-9. doi: 10.1210/en.2006-0716. Epub 2006 Nov 16. Endocrinology. 2007. PMID: 17110431

7

ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor.

Yang Z, Chang YJ, Yu IC, Yeh S, Wu CC, Miyamoto H, Merry DE, Sobue G, Chen LM, Chang SS, Chang C. Yang Z, et al. Nat Med. 2007 Mar;13(3):348-53. doi: 10.1038/nm1547. Epub 2007 Mar 4. Nat Med. 2007. PMID: 17334372

8

Promotion of bladder cancer development and progression by androgen receptor signals.

Miyamoto H, Yang Z, Chen YT, Ishiguro H, Uemura H, Kubota Y, Nagashima Y, Chang YJ, Hu YC, Tsai MY, Yeh S, Messing EM, Chang C. Miyamoto H, et al. Among authors: yang z. J Natl Cancer Inst. 2007 Apr 4;99(7):558-68. doi: 10.1093/jnci/djk113. J Natl Cancer Inst. 2007. PMID: 17406000

9

Correction to: Androgen receptor regulates expression of skeletal muscle-specific proteins and muscle cell types.

Altuwaijri S, Lee DK, Chuang KH, Ting HJ, Yang Z, Xu Q, Tsai MY, Yeh S, Hanchett LA, Chang HC, Chang C. Altuwaijri S, et al. Among authors: yang z. Endocrine. 2020 Aug;69(2):474-475. doi: 10.1007/s12020-020-02350-0. Endocrine. 2020. PMID: 32617754

10

PGC1α as a downstream effector of KDM5B promotes the progression of androgen receptor-positive and androgen receptor-negative prostate cancers.

Teramoto Y, Yang Z, Matsukawa T, Najafi MAE, Goto T, Miyamoto H. Teramoto Y, et al. Among authors: yang z. Am J Cancer Res. 2024 Sep 15;14(9):4367-4377. doi: 10.62347/QWZY6886. eCollection 2024. Am J Cancer Res. 2024. PMID: 39417173 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49,881 results

Search Page

Filters